Is a complete IMMP research report available?

No complete published report is available for Immutep Limited (IMMP) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Immutep Limited (IMMP)

NASDAQ: IMMP · USD

$0.38

-0.01 (-2.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-27 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first IMMP analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	49.5M
Revenue (ttm)	5.3M
Net income (ttm)	-56M
EPS (ttm)	-$0.04
Shares out	1.5B
Volume	226,761
Beta	2.22
Price target	$1.50	+290.1%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 5.3M
Net income (ttm): -56M
EPS (ttm): -$0.04
Market cap: 49.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All IMMP indicators

Market & fundamental data

Available fields

198

Groups with data

Currency

AUD

Showing 198 of 198 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001692528
Company name	Immutep Limited
Country	Australia
Country code	US
Cusip	45257L108
Employees	31
Employees Change	1%
Employees Change Percent	3.33
Enterprise value	$-19M
Exchange	NASDAQ
Financial currency	AUD
First seen	2026-05-09
Industry	Biotechnology
Isin	US45257L1089
Last refreshed	2026-07-27
Market cap	$49.5M
Market cap category	Nano-Cap
Price	$0.38
Price currency	USD
Rev Per Employee	170,472.23x
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.79
Symbol	IMMP
Website	https://www.immutep.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-113.15%
FCF yield	-87.85%
P/B ratio	0.75x
P/S ratio	9.36x
PS Forward	2.38x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-178,671.77%
EBITDA Margin	-178,671.77%
Gross Profit	$-49.9M
Net Income	$-56M
Net Income Growth Years	0%
Pretax Margin	-1,059.19%
Profit Per Employee	$-1.8M
ROA	-32.1
Roa5y	-20.43
ROCE	-96.58
ROE	-61.85
Roe5y	-38.46
ROIC	-38.57

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-18.75%
Cagr1y	-77.14%
Cagr3y	-44.98%
Cagr5y	-35.82%
EPS Growth Years	0
Revenue Growth	62.39x
Revenue Growth Q	91.46x
Revenue Growth Years	2x
Revenue Growth3 Y	22.43x
Revenue Growth5 Y	4.51x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.05
Assets	$98.2M
Cash	$66.1M
Current Assets	$97.5M
Current Liabilities	$32.8M
Debt	$806,834
Debt Equity	$0.01
Equity	$66M
Interest Coverage	-2,474.9
Liabilities	$32.2M
Long Term Assets	$643,474
Long Term Liabilities	$-585,797
Net Cash	$65.3M
Net Cash By Market Cap	$132
Net Cash Growth	-4.11%
Net Debt Equity	$-0.99
Tangible Book Value	$62M
Tangible Book Value Per Share	$0.04
WACC	16.23

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.97
Net Working Capital	$-4.1M
Quick ratio	2.91
Working Capital	$61.9M
Working Capital Turnover	$0.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-9.74%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-87.46%
1Y total return	-77.11%
200-day SMA	1.49
3Y total return	-83.35%
50-day SMA	0.42
50-day SMA vs 200-day SMA	50under200
5Y total return	-89.11%
All Time High	46.67
All Time High Change	-99.18%
All Time High Date	2012-04-17
All Time Low	0.29
All Time Low Change	31.32%
All Time Low Date	2026-04-13
ATR	0.03
Beta	2.22
Ch YTD	-86.56
High	0.41
High52	3.53
High52 Date	2025-12-08
High52ch	-89.11%
Low	0.38
Low52	0.29
Low52 Date	2026-04-13
Low52ch	31.32%
Ma50ch	-7.77%
Premarket Change Percent	0
Premarket Price	$0.39
Premarket Volume	354
Price vs 200-day SMA	-74.26%
RSI	40.18
RSI Monthly	34.44
RSI Weekly	31.85
Sharpe ratio	-0.15x
Sortino ratio	-0.17
Total Return	-9.74%
Tr YTD	-86.56
Tr1m	-2.39%
Tr1w	-6.17%
Tr3m	-32.65%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	0
Analyst Ratings	Buy
Earnings Revenue Estimate	2,530,000x
Earnings Revenue Estimate Growth	-61.79x
Operating Income	$-56.4M
Operating margin	-1,068.1
Price target	$1.5
Price Target Change	$290

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,430,348,303%
Float Percent	97.06%
Net Borrowing	-184,915.7
Shares Insiders	2.66%
Shares Institutions	55.15%
Shares Out	1,473,721,306
Shares Qo Q	0.84%
Shares Yo Y	9.74%
Short Ratio	6.56
Short Shares	2.72

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-44.2M
Average Volume	373,515.05x
Bv Per Share	0.04
CAPEX	$-88,568
Ch10y	-87.46
Ch1m	-2.39
Ch1w	-6.17
Ch1y	-77.11
Ch3m	-32.65
Ch3y	-83.35
Ch5y	-89.11
Ch6m	-87.87
Change	-2.01%
Change From Open	-0.39
Close	0.39
Days Gap	-1.63
Depreciation Amortization	1,556,079.1
Dollar Volume	87,189.6
Earnings Date	2026-07-29
Earnings Time	bmo
EBIT	$-64.5M
EBITDA	$-64.5M
EPS	$-0.04
F Score	2
FCF	$-43.5M
FCF EV Yield	228.64x
FCF Per Share	$-0.03
Financing CF	-140,412
Fiscal Year End	June
Founded	1,987
Goodwill	76,731.5
Investing CF	39,753,364
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-02-25
Last Report Date	2025-12-31
Last Split Date	2016-12-28
Last Split Type	Reverse
Ma150	1.36
Ma150ch	-71.67%
Ma20	0.42
Ma20ch	-8.04%
Net CF	-759,461
Next Earnings Date	2026-08-07
Open	0.39
Optionable	Yes
Position In Range	16.54
Post Close	0.38
Postmarket Change Percent	2.99
Postmarket Price	$0.4
Ppne	919,801.1
Pre Close	0.39
Price Date	2026-07-24
Ptbv Ratio	0.8
Relative Volume	0.61x
Revenue	5,284,639x
SBC By Revenue	14.69x
Share Based Comp	776,109
Tr6m	-87.87%
Volume	226,761
Z Score	-0.55

Immutep Limited (IMMP)

Coverage state: Market snapshot only — no published research

Generate the first IMMP analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · IMMP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IMMP indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on IMMP

Frequently asked questions